Mar 20, 2026 07:30AM Anavex cites study supporting autophagy failure theory in Alzheimer's

Mar 17, 2026 07:30AM Anavex Life Sciences reports blarcamesine study results in Parkinson's model

Feb 9, 2026 08:09AM Anavex Life Sciences (AVXL) Tops Q1 EPS by 6c

Jan 20, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Dec 18, 2025 07:31AM Anavex requests EMA to re-examine blarcamesine for Alzheimer's

Nov 28, 2025 06:36AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Nov 19, 2025 06:39AM Anavex Life Sciences (AVXL) PT Lowered to $20 at H.C. Wainwright

Nov 14, 2025 07:31AM Anavex receives negative vote from European regulators on Alzheimer drug

Oct 29, 2025 07:35AM Anavex reports long-term cognitive benefits from blarcamesine in alzheimer's trial

Oct 23, 2025 04:03PM Jones Trading Downgrades Anavex Life Sciences (AVXL) to Hold

Oct 10, 2025 07:30AM ANAVEX presents Alzheimer's drug research at European conference

Oct 7, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Oct 2, 2025 07:35AM Anavex Life Sciences develops once-daily tablet for ANAVEX3-71 drug

Sep 11, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Aug 26, 2025 07:31AM ANAVEX publishes research on blarcamesine autophagy mechanism

Aug 22, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Aug 20, 2025 07:30AM Anavex reports study showing blarcamesine prevented memory loss in mice

Jul 31, 2025 07:32AM Anavex reports blarcamesine shows cognitive benefits in alzheimer's trial

Jul 25, 2025 04:52PM Anavex Life Sciences (AVXL) Files for $150M Offering of Common Stock

May 13, 2025 05:48PM Anavex Life Sciences (AVXL) Tops Q2 EPS by 2c

May 1, 2025 07:30AM Anavex Life Sciences (AVXL) Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia

Apr 7, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Mar 31, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Feb 18, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Jan 28, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Jan 27, 2025 07:30AM Anavex Life Sciences (AVXL) Announces Issuance of Blarcamesine Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

Jan 15, 2025 07:30AM Anavex Life Sciences (AVXL) Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease

Dec 26, 2024 06:35AM Anavex Life Sciences (AVXL) PT Raised to $42 at H.C. Wainwright

Dec 23, 2024 02:59PM Anavex Life Sciences (AVXL) call put ratio 4 calls to 1 put with a focus on January calls as share price up 30%

Oct 18, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Oct 17, 2024 07:30AM Anavex Life Sciences (AVXL) Reports Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX3-71

Aug 6, 2024 01:49PM Jones Trading Reiterates Buy Rating on Anavex Life Sciences (AVXL)

Jul 29, 2024 07:15AM Anavex Life Sciences (AVXL): Results from Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference

Jul 22, 2024 07:01AM EF Hutton Starts Anavex Life Sciences (AVXL) at Buy